Drug recall · July 26, 2023
Loteprednol Etabonate Ophthalmic Suspension recall
Why: Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.
- Lots / codes
Lot#: a) BAC0334A, Exp 06/2023; BAC0532A, Exp 11/2023 BAD0407A, Exp 08/2024 BAD0425A, Exp 08/2024; b) BAC0335A, Exp 06/2023, BAC0533A, Exp 10/2023, BAD0148A, Exp 03/2024, BAD0320A, Exp 07/2024
- Quantity
- 20,884 cartons
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- USA nationwide.
- Initiated
- July 5, 2023 · Voluntary: Firm initiated
- Classified
- July 17, 2023
- Reported
- July 26, 2023
- Ended
- February 26, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Loteprednol etabonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.